Figure 2.
Overall sustained virological response 12 weeks after completion of treatment (SVR12) of direct-acting antiviral therapies for chronic hepatitis C genotype 3 in Asia.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.